Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Emyria Ltd ( (AU:EMD) ) has provided an update.
Emyria Ltd has announced its Annual General Meeting (AGM) scheduled for November 13, 2025, at Stantons International in West Perth, Australia. The AGM will address the company’s annual report and include resolutions on the remuneration report and the election of Dr. Michael Winlo as a director. Shareholders are encouraged to participate and vote, with the meeting set to discuss key governance and strategic decisions impacting the company’s future direction.
More about Emyria Ltd
Emyria Ltd operates in the healthcare industry, focusing on the development and commercialization of innovative medical treatments and technologies. The company is involved in providing solutions that cater to unmet medical needs, with a particular emphasis on leveraging data and technology to enhance patient care and outcomes.
Average Trading Volume: 4,625,502
Technical Sentiment Signal: Buy
Current Market Cap: A$43.22M
For an in-depth examination of EMD stock, go to TipRanks’ Overview page.